NCT02476123View on ClinicalTrials.gov

Study of Combination Therapy With Mogamulizumab (KW-0761) and Nivolumab (ONO-4538/BMS-936558) in Subjects With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

February 7, 2018

Study Completion Date

December 21, 2018

Conditions
Solid Tumor
Interventions
BIOLOGICAL

Mogamulizumab: KW-0761, Nivolumab: (ONO-4538/BMS-936558)

i.v. administration

Trial Locations (2)

Unknown

Chiba

Tokyo

Sponsors
All Listed Sponsors
collaborator

Ono Pharmaceutical Co. Ltd

INDUSTRY

lead

Kyowa Kirin Co., Ltd.

INDUSTRY